You have 9 free searches left this month | for more free features.

Retinoic Acid Receptor Alpha (RARA) positive

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

Not yet recruiting
  • Breast Cancer
  • laboratory test (RAI14 and MACC-1 )
  • (no location specified)
Oct 18, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • (no location specified)
Nov 8, 2022

Endometrial Cancer Trial in New Haven (IMGN853)

Recruiting
  • Endometrial Cancer
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 10, 2022

Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)

Not yet recruiting
  • Breast Cancer Female
  • All trans-retinoic acid
  • +6 more
  • (no location specified)
Aug 17, 2021

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 11, 2022

Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

Recruiting
  • Acute Myeloid Leukemia
  • Tucson, Arizona
  • +8 more
Jan 3, 2023

Vestibular Function Disorder Trial in San Antonio (Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg)

Not yet recruiting
  • Vestibular Function Disorder
  • Alpha Lipoic Acid 300mg
  • Coenzyme Q10 200mg
  • San Antonio, Texas
    University of Texas Health Science Center at San Antonio
Jul 5, 2023

Healthy Trial (Alcohol, Alcohol+protein, Alcohol+retinol)

Not yet recruiting
  • Healthy
  • Alcohol
  • +3 more
  • (no location specified)
Oct 25, 2023

Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)

Recruiting
  • Ischemic Cardiomyopathy
  • Diabetes Mellitus
  • Alpha Lipoic Acid 600 MG Oral Tablet
  • Placebo Tablet
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023

Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)

Recruiting
  • Solid Tumor, Adult
  • HF1K16 /Arm 45 mg/m2
  • +3 more
  • Shanghai, Shanghai, China
  • +2 more
May 23, 2022

Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)

Recruiting
  • Metabolic Associated Fatty Liver Disease
  • LUDLEV®300 mg/46.2 mg
  • Placebo
  • Mexico, Veracruz, Mexico
    Ana Delfina Cano Contreras
Jun 12, 2023

Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

Recruiting
  • Glaucoma, Suspect
  • Aberration, Corneal Wavefront
  • Low dosage selective alpha-2 receptor agonists topical eyedrop
  • High dosage selective alpha-2 receptor agonists topical eyedrop
  • Banhā, QA, Egypt
    Ahmed Abdelshafy
Jan 2, 2023

Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer Trial in Worldwide (AZD5363 when combined with

Completed
  • Advanced or Metastatic Breast Cancer
  • ER+ve Advanced or Metastatic Breast Cancer
  • AZD5363 when combined with weekly paclitaxel.
  • +2 more
  • Plovdiv, Bulgaria
  • +40 more
Dec 23, 2022

Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,

Not yet recruiting
  • Post COVID-19 Anosmia (Loss of Smell)
  • Aerosolized 13 cis retinoic acid plus Vitamin D
  • +2 more
  • Foshan, Guangdong, China
  • +2 more
Nov 9, 2021

Breast Cancer, Perioperative Period, Dexmedetomidine Trial (Dexmedetomidine, Esketamine, Normal saline)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Feb 7, 2023

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

Not yet recruiting
  • Breast Cancer
  • Beijing, Benjing, China
  • +2 more
Dec 30, 2022

Healthy Trial in Petaling Jaya (Serum with low concentration AHA (1% Glycolic acid and Lactic acid) and PGA)

Recruiting
  • Healthy
  • Serum with low concentration AHA (1% Glycolic acid and Lactic acid) and PGA
  • Petaling Jaya, Selangor, Malaysia
    Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) C
Aug 15, 2023

Neuroendocrine Tumors Trial in Houston (AlphaMedix)

Recruiting
  • Neuroendocrine Tumors
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jan 5, 2022

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)

Not yet recruiting
  • Diabetes MellitusType 1
  • Placebo
  • Alpha Lipoic Acid 600 MG Oral Capsule
  • (no location specified)
Jan 8, 2023

ERT in Pompe Disease: Elucidation of Molecular Structures

Not yet recruiting
  • Pompe-Disease
    • Rüsselsheim, Hessen, Germany
      Centre for Analytical Biochemistry
    Jan 30, 2023

    Inherited Retinal Dystrophy Primarily Involving Sensory Retina Trial (Disulfiram 250 mg, Placebo)

    Not yet recruiting
    • Inherited Retinal Dystrophy Primarily Involving Sensory Retina
    • Disulfiram 250 mg
    • Placebo
    • (no location specified)
    Nov 22, 2022

    Brain Tumors Trial in Canada, United States (temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid)

    Completed
    • Brain Tumors
    • temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
    • Phoenix, Arizona
    • +16 more
    Jun 17, 2021